AlphaStocks
4.3
Weak

Medpace Holdings, Inc. (MEDP)

Health Care / Life Sciences Tools & Services

S&P MidCap 400

$489.24

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

#769out of 1127 in Health Care

Is Medpace Holdings, Inc. a Good Investment in 2026?

Medpace Holdings, Inc. (MEDP) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Lynch model rates Medpace Holdings, Inc. as Strong (PEG 0.5 · Fast Grower). However, the Graham model rates it Caution — Significantly above fair value. Medpace Holdings, Inc. currently trades above its estimated fair value of $410, suggesting limited upside at current prices. Medpace Holdings, Inc. ranks #769 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E32.0ROE48.9Market Cap14B

Estimated Fair Value

$410.3519% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Strong

PEG 0.5 · Fast Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Medpace Holdings, Inc. (MEDP) a good investment?
Based on AlphaStocks' composite analysis, Medpace Holdings, Inc. (MEDP) scores 4.3 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading slightly above estimated fair value.
What is Medpace Holdings, Inc.'s Piotroski F-Score?
Medpace Holdings, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MEDP overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $410, MEDP appears overvalued. The stock currently trades 19% above its estimated fair value. Trading slightly above estimated fair value.
How does MEDP compare to other Health Care stocks?
Medpace Holdings, Inc. ranks #769 out of 1127 stocks in the Health Care sector, placing it in the top 68% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about MEDP?
AlphaStocks evaluates MEDP using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Strong. These models are combined into a single composite score of 4.3/10.

Similar Stocks

PARRFTIAZN

Compare MEDP with

MEDP vs PARRMEDP vs FTIMEDP vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer